4.7 Article

Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffei

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species

Ashutosh Singh et al.

Summary: Olorofim demonstrates potent in vitro activity against drug-resistant dermatophytes and opportunistic moulds, with exceptions in Alternaria alternata. When compared to other systemic antifungal drugs, Olorofim exhibits lower activity against Penicillium and Talaromyces species. Particularly, Olorofim shows strong activity against Trichophyton isolates, including those resistant to terbinafine and azoles.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Infectious Diseases

Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim

Wilson Lim et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Review Pharmacology & Pharmacy

Innovative therapies for invasive fungal infections in preclinical and clinical development

Yidong Yu et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Article Mycology

New section and species in Talaromyces

Bing-Da Sun et al.

MYCOKEYS (2020)

Article Infectious Diseases

In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies

Olga Rivero-Menendez et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Microbiology

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis

Nathan P. Wiederhold et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Infectious Diseases

In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates

J. B. Buil et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Infectious Diseases

Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans

Nathan P. Wiederhold et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Multidisciplinary Sciences

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

Jason D. Oliver et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Infectious Diseases

Neglected fungal zoonoses: hidden threats to man and animals

S. Seyedmousavi et al.

CLINICAL MICROBIOLOGY AND INFECTION (2015)

Article Infectious Diseases

Investigation of dogs as a reservoir of Penicillium marneffei in northern Thailand

Benjaporn Chaiwun et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)

Article Microbiology

In vitro activities of four novel triazoles against Scedosporium spp.

AJ Carrillo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)